Oregon State University scientists have developed a nanomedicine platform for cancer that can help doctors know which tissue to cut out as well as kill any malignant cells that can’t be surgically removed.
The platform allows for greater precision and thoroughness in cancer treatment.
Here’s how it works:
Nanoparticles tightly loaded with a dye compound are administered systemically – injected intravenously or into the peritoneum, the abdominal cavity. When they reach the tumor site, the tumor’s intracellular environment effectively flips the switch on the compound’s fluorescence.
That enables detection by a near infrared (NIR) imaging system that helps surgeons know in real time what needs to be removed.
Any glowing areas that can’t be cut out are given phototherapy – irradiated with a near infrared laser, which causes the nanoparticles to heat up and kill the residual cancer cells.
The findings by researchers in the OSU/OHSU College of Pharmacy and OSU College of Veterinary Medicine were published this month in Theranostics.
The nanomedicine platform consists of silicon naphthalocyanine (SiNc) densely packed in biodegradable PEG-PCL nanoparticles. Because the SiNc is engineered to be non-fluorescent initially – until the tumor activates the fluorescence by loosening the packing – it doesn’t cause any non-cancerous tissue to glow.
Corresponding authors Olena Taratula and Oleh Taratula of the Department of Pharmaceutical Sciences and their collaborators evaluated the platform in vitro and in two different mouse models, including one that mimicked ovarian intraperitoneal metastasis.
The research team operated on the mice using real-time imaging, which showed that the new nanoparticles are compatible with a standard, FDA-approved imaging system. The efficacy of the phototherapy was also demonstrated in vivo.
“The nanoplatform system is quite simple but quite effective,” Olena Taratula said.
Subsequent laboratory testing of the platform will include rats, she said, followed by testing on dogs that are already scheduled for cancer surgeries at the College of Veterinary Medicine.
“They’re going to do surgery on those dogs anyway, and they can use our nanomedicine platform as an additional tool to see if they can identify the cancer cells,” Taratula said.
The Latest on: Flourescent nanomedicine
- Liposomal Nanomedicine for Breast Cancer Therapyon July 23, 2019 at 5:00 pm
Multifunctional liposomes, which utilize molecular alterations/expressions by tumor cells, remains the thrust area of research in the field of nanomedicine for breast cancer therapy.
- Glutathione-mediated biotransformation in the liver modulates nanoparticle transporton July 15, 2019 at 8:19 am
By designing a thiol-activatable fluorescent gold nanoprobe that can bind to serum ... With this biotransformation, liver detoxification, a long-standing barrier in nanomedicine translation, can be ...
- New optical imaging system could be deployed to find tiny tumorson March 7, 2019 at 6:37 am
Researchers have developed a near-infrared fluorescent optical imaging system that could ... the Marble Center for Cancer Nanomedicine, the Koch Institute Support (core) Grant from the National Cancer ...
- Nanoparticles Highlight Organ Transplant Rejection Through Fluorescent Urineon February 21, 2019 at 12:28 pm
The nanoparticles can accumulate in transplanted organs and detect immune rejection, whereupon they release molecules that turn the urine of the organ recipient fluorescent. Using a simple urine test, ...
- MSK-Cornell Center for Translation of Cancer Nanomedicineon March 6, 2018 at 8:33 am
The goal of the MSK-Cornell Center for Translation of Cancer Nanomedicine (MC 2 TCN) is to advance, translate, and disseminate a suite of ultrasmall (
- Fluorescent Nanomedicine Guiding Tumor Removalon February 1, 2018 at 4:00 pm
A nanomedicine platform has been developed for use with the treatment of cancer that will help doctors to know which tissue to cut away for removal as well as kill any malignant cells which are not ...
- Fluorescent nanomedicine can guide tumor removal, kill remaining cancer cellson December 20, 2017 at 4:00 pm
Oregon State University scientists have developed a nanomedicine platform for cancer that can help doctors know which tissue to cut out as well as kill any malignant cells that can't be surgically ...
- Nanomedicine applications in women's health: state of the arton July 19, 2017 at 5:00 pm
Nanomedicine may offer the potential to improve the efficacy ... 128 However, it was found that ultra-bright fluorescent mesoporous silica NPs, functionalized with FA, exhibit greater fluorescence and ...
via Google News and Bing News